Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henderik W Frijlink

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2003
Benefits of different drug formulations in psychopharmacologyHenderik W Frijlink
Drug Discovery Today. Technologies|July 2, 2014
Trends in the technology-driven development of new inhalation devicesHenderik W Frijlink, Anne H de Boer
Expert Review of Vaccines|March 22, 2021
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19Rick Heida, Wouter Lj Hinrichs, Henderik W Frijlink
Mbio|September 28, 2023
Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administrationRick Heida, Henderik W Frijlink, Wouter L J Hinrichs
Human Vaccines|October 9, 2010
Dried influenza vaccines: over the counter vaccinesVinay Saluja, Wouter L J Hinrichs, Henderik W Frijlink
Drug Discovery Today|February 10, 2015
Polymeric formulations for drug release prepared by hot melt extrusion: application and characterizationMilica Stanković, Henderik W Frijlink, Wouter L J Hinrichs
Pharmaceutics|January 25, 2025
What Is the Optimal Geometry of Dissolving Microneedle Arrays? A Literature ReviewMaira Visscher, Henderik W Frijlink, Wouter L J Hinrichs
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 12, 2014
A proposed definition of the 'activity' of surface sites on lactose carriers for dry powder inhalationFloris Grasmeijer, Henderik W Frijlink, Anne H de Boer
Pharmaceutics|May 16, 2019
Characterization and Formulation of Isoniazid for High-Dose Dry Powder InhalationImco Sibum, Paul Hagedoorn, Henderik W Frijlink, et al.
European Journal of Clinical Pharmacology|January 27, 2019
A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environmentKarin H M Larmené-Beld, Henderik W Frijlink, Katja Taxis
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2003
Benefits of different drug formulations in psychopharmacologyHenderik W Frijlink
Drug Discovery Today. Technologies|July 2, 2014
Trends in the technology-driven development of new inhalation devicesHenderik W Frijlink, Anne H de Boer
Expert Review of Vaccines|March 22, 2021
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19Rick Heida, Wouter Lj Hinrichs, Henderik W Frijlink
Mbio|September 28, 2023
Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administrationRick Heida, Henderik W Frijlink, Wouter L J Hinrichs
Human Vaccines|October 9, 2010
Dried influenza vaccines: over the counter vaccinesVinay Saluja, Wouter L J Hinrichs, Henderik W Frijlink
Drug Discovery Today|February 10, 2015
Polymeric formulations for drug release prepared by hot melt extrusion: application and characterizationMilica Stanković, Henderik W Frijlink, Wouter L J Hinrichs
Pharmaceutics|January 25, 2025
What Is the Optimal Geometry of Dissolving Microneedle Arrays? A Literature ReviewMaira Visscher, Henderik W Frijlink, Wouter L J Hinrichs
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 12, 2014
A proposed definition of the 'activity' of surface sites on lactose carriers for dry powder inhalationFloris Grasmeijer, Henderik W Frijlink, Anne H de Boer
Pharmaceutics|May 16, 2019
Characterization and Formulation of Isoniazid for High-Dose Dry Powder InhalationImco Sibum, Paul Hagedoorn, Henderik W Frijlink, et al.
European Journal of Clinical Pharmacology|January 27, 2019
A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environmentKarin H M Larmené-Beld, Henderik W Frijlink, Katja Taxis
Pageof 20